Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AstraZeneca AB et al v. Dr. Reddy's Laboratories, Inc.
Case Number:
1:15-cv-00988
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
July 21, 2016
Dr. Reddy's Countersuit Rejected In Purple Pill Trademark Row
A Delaware federal judge on Wednesday told Dr. Reddy's Laboratories Inc. that it can't move AstraZeneca's trademark infringement suit over Dr. Reddy's purple generic of the heartburn drug Nexium to New Jersey, and dismissed counterclaims that the lawsuit breached an earlier settlement agreement.
-
November 25, 2015
Dr. Reddy's Denied Stay In AstraZeneca Purple Pill Row
A Delaware federal judge on Wednesday shot down Dr. Reddy's Laboratories Inc.'s attempt to keep selling its generic version of AstraZeneca's trademarked purple pill, the heartburn drug Nexium, following a temporary restraining order against the Indian company earlier this month.
-
November 06, 2015
AstraZeneca Blocks Dr. Reddy's Purple Heartburn Pills
A Delaware federal judge on Friday granted AstraZeneca's request for a temporary restraining order barring Dr. Reddy's Laboratories Inc. from selling a generic version of heartburn drug Nexium that allegedly infringes on the pharmaceutical giant's trademarked purple pill.
-
October 29, 2015
AstraZeneca Says Dr. Reddy's Heartburn Pill Can't Be Purple
AstraZeneca has asked a Delaware federal court to bar Dr. Reddy's Laboratories from introducing a purple generic version of the heartburn medication Nexium, saying the color is trademarked and will confuse customers.